SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-045194
Filing Date
2023-08-09
Accepted
2023-08-09 16:38:19
Documents
1
Period of Report
2023-08-09

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 14992
  Complete submission text file 0001209191-23-045194.txt   16635
Mailing Address C/O CATALYST BIOSCIENCES, INC. 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080
Business Address
TETLOW SHARON (Reporting) CIK: 0001328565 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40794 | Film No.: 231155814

Mailing Address 400 EAST JAMIE COURT SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 400 EAST JAMIE COURT SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-566-1402
DICE Therapeutics, Inc. (Issuer) CIK: 0001645569 (see all company filings)

IRS No.: 472286244 | State of Incorp.: DE | Fiscal Year End: 1230
SIC: 2834 Pharmaceutical Preparations